Medicaid, Biden and Obesity

Biden Administration Proposes Covering Obesity Drugs In Medicare And Medicaid
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive decisions made by the incoming Trump administration.
7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposal
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal being unveiled Tuesday by the Biden administration.
Biden Says Medicare, Medicaid Should Cover Obesity Drugs—What Could That Mean for Access?
Fact checked by Nick Blackmer The Biden Administration proposed a new rule that would require Medicare and Medicaid to cover some anti-obesity medications for people who are obese, beginning in 2026.More than 40% of Americans have obesity,
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Biden administration unveils plan to cover weight loss meds under Medicare, Medicaid
WASHINGTON — The Biden administration announced last Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the long term.
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal
The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover obesity medications, a costly and probably popular move that the Trump administration would need to endorse to become official.
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Does Medicare cover for anti-obesity medications? Find about the eligibility
The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the condition, including anti-obesity medications. However, man
Biden administration proposes expanding obesity drug coverage under Medicare and Medicaid
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.
Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaid
Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like semaglutide (Wegovy) or tirzepatide (Zepbound) under a regulation proposed Tuesday by the Centers for Medicare & Medicaid Services (CMS).
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
Yahoo7d
Biden proposes Medicare, Medicaid coverage of obesity drugs
The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be ...
phillyvoice.com7d
Obesity drugs would be covered by Medicare and Medicaid under Biden administration proposal
An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...